The Global Western Blotting Market size is set to grow by USD 1.4 billion by 2026 according to MarketsandMarkets. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.
Technological advancements in lab freezers also drive the growth of this market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The global Western Blotting market is fragmented, and the degree of fragmentation will accelerate during the forecast period.
Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711
Western Blotting Market Segmentation
Global Western Blotting Market, by Application
- Biomedical Research
- Clinical Diagnostics
- Agricultural Applications
- Other Applications
Geography
- North America
- Europe
- Asia
- ROW
Global Western Blotting Market Vendor Analysis
To help businesses improve their market position, MnM report provides a detailed analysis of around 25 vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235810711
Some of the major vendors of the global Western Blotting market in the health care industry include:
Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany).
Regional Analysis
Asia Pacific region accounted for the fast growing region of the western blotting market. . The major factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bio clusters in China and India, increasing funding for life science research, and growing initiatives related to target disease diagnosis.
Global Western Blotting Market Key Highlights
- CAGR of the market during the forecast period
- Detailed information on factors that will assist global Western Blotting market growth during the next five years
- Estimation of the global Western Blotting market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the global Western Blotting market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of global Western Blotting market vendors
Key Developments in Global Western Blotting Market
- In September 2021, PerkinElmer, Inc. (US) acquired BioLegend (US), a leading provider of life science antibodies and reagents, including primary antibodies and western blot secondary reagents. This acquisition enhances the company’s existing western blotting product portfolio.
- In August 2021, Abcam Plc (UK) acquired BioVision Inc. (US), a global supplier of life science research tools for research, diagnostics, and drug discovery. The company is a leading provider of biochemical and cell-based assays and produces a wide portfolio of other products, including recombinant proteins, antibodies, enzymes, and biochemical compounds for immunoassay technologies such as western blotting
- In April 2021, Bio-Techne Corporation (US) launched Abby, a next-generation chemiluminescence system that automates traditional western blotting
Each of these players has been profiled in the global Western Blotting market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
To speak to our analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235810711
